1. Евсюкова И.И., Кошелева Н.Г. Сахарный диабет: беременные и новорожденные. 2-е изд., перераб. и доп. Москва: Миклош, 2009. 272 с.
2. Евсюкова И.И. Молекулярные механизмы функционирования системы «мать — плацента — плод» при ожирении и гестационном сахарном диабете // Молекулярная медицина. 2020. Т. 18, № 1. С. 11–15.
3. Ковальчук-Ковалевская О.В., Евсюкова И.И. Использование нейропротекции в лечении новорожденных детей с задержкой функционального развития ЦНС // Педиатрия. 2012. Т. 91, № 6. С. 129–134.
4. Педерсен Е. Диабет у беременной и ее новорожденный. Москва: Медицина, 199. 333 с.
5. Федорова М.В., Краснопольский В.И., Петрухин В.А. Сахарный диабет, беременность и диабетическая фетопатия. Москва: Медицина, 2001. 288 с.
6. Харитонова Л.А., Папышева О.В., Катайш Г.А. и др. Состояние здоровья детей от матерей с сахарным диабетом // Российский вестник перинатологии и педиатрии. 2018. Т. 63, № 3. С. 26–31.
7. Allard C., Desgagné V., Patenaude J., Lacroix M., Guillemette L., Battista M.C. et al. Mendelian randomization supports causality between maternal hyperglycemia and epigenetic regulation of leptin gene in newborns // Epigenetics. 2015. Vol. 10, N 4. P. 342–351. DOI: 10.1080/15592294.2015.1029700.
8. Allen V.M., Armson B.A., Wilson R.D. et al. Teratogenicity associated with pre-existing and gestational diabetes // J. Obstet. Gynaecol. Can. 2007. Vol. 29, N 11. P. 927–924.
9. Al-Biltagi M., Tolba O.A., Rowisha M.A., Mahfouz Ael-S., Elewa M.A. Speckle tracking and myocardial tissue imaging in infant of diabetic mother with gestational and pregestational diabetes // Pediatr. Cardiol. 2015. Vol. 36, N 2. P. 445–453.
10. Banci M., Saccucci P., Dofcaci A., Sansoni I., Magrini A., Bottini E., Gloria-Bottini F. Birth weight and coronary artery disease. The effect of gender and diabetes // Int. J. Biol. Sci. 2009. Vol. 5, N 3. P. 244–248. DOI: 10.7150/ijbs.5.244.
11. Boney C.M., Verma A., Tucker R., Vohr B.R. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus // Pediatrics. 2005. Vol. 115, N 3. P. 290–296.
12. Chang T.I., Horal M., Jain S.K., Wang F., Patel R., Loeken M.R. Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects // Diabetologia. 2003. Vol. 46, N 4. Р. 538–545.
13. Chiavaroli V., Castorani V., Guidone P., Derraik J.G., Liberati M., Chiarelli F., Mohn A. Incidence of infants born small- and large-for-gestational-age in an Italian cohort over a 20-year period and associated risk factors // Ital. J. Pediatr. 2016. Vol. 42. P. 42. DOI: 10.1186/s13052-016-0254-7.
14. Chavey A., Ah Kioon M.D., Bailbé D., Movassat J., Portha B. Maternal diabetes, programming of beta-cell disorders and intergenerational risk of type 2 diabetes // Diabet. Metab. 2014. Vol. 40, N 5. P. 323–330. DOI: 10.1016/j.diabet.2014.02.003.
15. Сitin H., Yalaz M., Akisu M., Kuliursay N. Plycythaemia in Infants of Diabetic Mothers: β-Hydroxybutyrate Stimulates Erythropoetic Activity // J. Inter. Med. Res. 2011.Vol. 39, N 3. P. 815–821.
16. Clausen T.D., Mortensen E.L., Schmidt L., Mathiesen E.R., Hansen T., Jensen D.M., Damm P. Cognitive function in adult offspring of women with gestational diabetes–the role of glucose and other factors // PLoS One. 2013. Vol. 8, N 6. P. e67107. DOI: 10.1371/journal.pone.0067107.
17. Cordero M.J.A., García L.B., Blanque R.R., García J.L., Villar N.M., López A.M.S. Diabetes MELLITUS materna y su influencia en el neurodesarrollo del niño; revisión sistemática [maternal diabetes mellitus and its impact on child neurodevelopment; systematic review] // Nutr. Hosp. 2015. Vol. 32, N 6. P. 2484–2495. Spanish. DOI: 10.3305/nh.2015.32.6.10069.
18. Cordero L., Paetow P., Landon M.V., Nankervis C.A. Neonatal outcomes of macrosomic infants of diabetic and nondiabetic mothers // J. Neonatal Perinatal. Med. 2015. Vol. 8, N 2. P. 105–112.
19. Dheen S.T., Tay S.S., Boran J., Ting L.W., Kumar S.D., Fu J., Ling E.A. Recent studies on neural tube defects in embryos of diabetic pregnancy: an overview // Curr. Med. Chem. 2009. Vol. 16, N 18. P. 2345–2354. DOI: 10.2174/092986709788453069.
20. Dilek M., Kumral A., Okyay E., Ozbal S., Tugyan K., Tuzun F. et al. Protective effects of pentoxifylline on lipopolysaccharide-induced white matter injury in a rat model of periventricular leukomalasia // J. Matern. Fetal. Neonatal. Med. 2013. Vol. 26, N 18. P. 1865–1871.
21. Grissa O., Yessoufou A., Mrisak I., Hichami A., Amoussou-Guenou D., Grissa A. et al. Growth factor concentrations and their placental mRNA expression are modulated in gestational diabetes mellitus: possible interactions with macrosomia // BMC Pregnancy Childbirth. 2010. Vol. 10. P. 7. DOI: 10.1186/1471-2393-10-7.
22. Hami J., Sadr-Nabavi A., Sankian M., Balali-Mood M., Haghir H. The effects of maternal diabetes on expression of insulin-like growth factor-1 and insulin receptors in male developing rat hippocampus // Brain Struct. Funct. 2013. Vol. 218, N 1. P. 73–84. DOI: 10.1007/s00429-011-0377-y.
23. Hsu C.N., Tain Y.L. Developmental programming and reprogramming of hypertension and kidney disease: impact of tryptophan metabolism // Int. J. Mol. Sci. 2020. Vol. 21, N 22. P. 8705. DOI: 10.3390/ijms21228705.
24. Kc K., Shakya S., Zhang H. Gestational diabetes mellitus and macrosomia: a literature review // Ann. Nutr. Metab. 2015. Vol. 66. Suppl. 2. P. 14–20.
25. Klemetti M., Nuutila M., Tikkanen M., Kari M.A., Hiilesmaa V., Teramo K. Trends in maternal BMI, glycaemic control and perinatal outcome among type 1 diabetic pregnant women in 1989–200 // Diabetologia. 2012. Vol. 55, N 9. P. 2327–2334. DOI: 10.1007/s00125-012-2627-9.